What is the recommended dose of epinephrine (adrenaline) in neonatal resuscitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epinephrine Dosing in Neonatal Resuscitation

The recommended dose of epinephrine in neonatal resuscitation is 0.01-0.03 mg/kg intravenously (IV) when heart rate remains below 60 beats per minute despite adequate ventilation and chest compressions; if IV access is unavailable, endotracheal administration at a higher dose of 0.05-0.1 mg/kg may be used while vascular access is being established. 1

Route of Administration and Dosing

Intravenous Administration (Preferred)

  • Dose: 0.01-0.03 mg/kg 2, 1
  • Concentration: 1:10,000 (0.1 mg/mL) 2
  • Frequency: Repeat every 3-5 minutes if heart rate remains <60 bpm 1
  • Higher IV doses (>0.03 mg/kg) are not recommended due to evidence of:
    • Exaggerated hypertension
    • Decreased myocardial function
    • Worse neurological outcomes
    • Increased postresuscitation mortality 2

Endotracheal Administration (Alternative)

  • Dose: 0.05-0.1 mg/kg 2, 1
  • Only to be used while IV access is being established 2, 1
  • Less effective than IV administration at equivalent doses 2
  • Higher doses are required endotracheally to achieve blood concentrations similar to IV administration 2

Clinical Decision Algorithm

  1. Assess need for epinephrine

    • Only indicated when heart rate remains <60 beats per minute despite:
      • Adequate ventilation with 100% oxygen
      • Effective chest compressions 2, 1
  2. Determine administration route

    • Attempt IV access (preferably umbilical venous catheter) first 2
    • If IV access cannot be rapidly established, proceed with endotracheal administration while continuing to establish IV access 2, 1
  3. Administer appropriate dose

    • IV route: 0.01-0.03 mg/kg
    • Endotracheal route: 0.05-0.1 mg/kg 2, 1
  4. Monitor response

    • Primary indicator: Increase in heart rate
    • If no response within 3-5 minutes, repeat dose 1

Important Considerations and Pitfalls

  • Epinephrine should not be administered until adequate ventilation and chest compressions have been established 2
  • Avoid delay in epinephrine administration once indicated 1
  • Dosing errors are common during neonatal resuscitation 3
    • Consider preparing standardized doses:
      • IV: 0.02 mg/kg (0.2 mL/kg of 1:10,000 solution) in a 1 mL syringe
      • ET: 0.1 mg/kg (1 mL/kg of 1:10,000 solution) in a 5 mL syringe 3
  • Despite widespread use, evidence supporting epinephrine in neonatal resuscitation is limited and largely extrapolated from pediatric and adult studies 4, 5
  • The 2020 systematic review found very low certainty evidence comparing endotracheal versus IV administration, with no significant differences in survival outcomes 5

The current recommendations are maintained by international resuscitation committees despite limited evidence, based on the best available data and clinical experience 1. Proper preparation and administration of epinephrine at the recommended doses is crucial for optimizing outcomes in neonatal resuscitation.

References

Guideline

Neonatal Resuscitation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

What is the optimal initial dose of epinephrine during neonatal resuscitation in the delivery room?

Journal of perinatology : official journal of the California Perinatal Association, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.